Amgen, Inc., Amgen Manufacturing, Ltd. - Jan. 22, 2016

$117.00
The current procedure … for determining the suitability for commercial distribution of batches manufactured prior to the process performance qualification campaign is inadequate for determining that drug substance lots manufactured prior to process performance qualification are adequate for release to the U.S. commercial market.